?you found? you sound surprised you were able to find a summary of the company’s announcement.
not sure how much you know about clinical trials. IMU for example is worth almost $2bn and their PD1-Vaxx clinical trial is 10 people. That’s less than half the size yet I don’t see you complaining about that company that you also don’t hold.
”flimsy” end point? a well designed trial will be able to show precise measurable impacts, not a binary outcome like live or die.
the desperation you and bargirl have in trying to downramp an achieved milestone. It must be really painful for you two to see CYP now recruiting in a second clinical trial. I expect it’s going to get more painful for both of you as CYP moves forward on its other 5 planned clinical trials and perhaps others yet to be announced. Holding the other company you hold and the series of failed end points by that company must have really scarred you.
at least you had the decency to add “IMO”.
?you found? you sound surprised you were able to find a summary...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.21M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $8.574K | 36.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30000 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 20475 | 2 |
View Market Depth
| Last trade - 15.43pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.000 ( 2.08 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 23.5¢ | 22.5¢ | 22626 | ||
| Last updated 13.57pm 07/05/2024 ? | |||||
| CYP (ASX) Chart |